Julie Sunderland

Julie Sunderland is the Managing Director at Biomatics Capital Partners in Seattle, Washington, specializing in investments at Series A stage in Seattle and Portland sectors. She notably invested in BlackThorn Therapeutics at the Series B stage, showcasing her strategic acumen and success in identifying promising companies for investment.